loader image
Thursday, October 30, 2025
56.2 F
McAllen
- Advertisement -

DHR Health Institute for Research and Development Recognized as a “Top Performing Site” Once Again

Translate to Spanish or other 102 languages!

THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
- Advertisement -

EDINBURG, Texas – The DHR Health Institute for Research and Development is delighted to announce that it has once again been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This marks the third consecutive time the Institute has received this prestigious distinction.

This recognition highlights the ongoing excellence and impact of the Research Institute as it continues to advance cancer research and improve patient outcomes.

“We are deeply honored and this recognition would not be possible without the assistance of the DHR Health Oncology Institute and the leadership of Dr. Jose Cruz,” said Dr. Scott Lillibridge, executive vice president for the DHR Health Institute for Research and Development.

- Advertisement -

SWOG is a global cancer research community supported by the National Cancer Institute (NCI), and recognition as a “Top Performing Site” signifies exceptional performance in clinical trial enrollment, data quality, and patient care standards.

The DHR Health Institute for Research and Development remains committed to innovation and delivering high-quality research opportunities to all residents of the Rio Grande Valley. They are located at 5323 S. McColl Road in Edinburg. For more information about clinical trials in the areas of liver, obesity, cancer, neurology, oncology and urology, call the Institute at (956) 362-2390.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Renaissance Cancer Foundation’s 15th Anniversary Gala Event, Nov. 15th

The Renaissance Cancer Foundation, a non-profit organization with DHR Health, is excited to announce its 15th Anniversary Gala, featuring the Miami sounds of music group, The Clique. The event is set to take place on November 15, 2025 at the Edinburg Conference Center at Renaissance, located at 118 Paseo Del Prado in Edinburg.

Mayo Clinic Study Finds Majority of Midlife Women with Menopause Symptoms Do Not Seek Care

A new study from Mayo Clinic underscores the widespread impact of menopause symptoms on midlife women — and raises concern that most are navigating this stage of life without medical care to help manage those challenges.

Research Reveals Genetic Link to Most Common Pediatric Bone Cancer

Researchers at Cleveland Clinic Children’s have helped identify a gene that increases the risk of developing osteosarcoma, which is the most common type of bone cancer in children and young adults. 

Edinburg Regional Medical Center’s Javen Hinojosa Among Winners of HeroesFirst Contest Award

Mega Doctor News KING OF PRUSSIA, Pa.– ImageFIRST®, the leading national provider of linen,...
- Advertisement -
×